The goal of this program under the Policy and Regulatory Issues component of Canadian HIV Vaccine Initiative (CHVI) is to support activities to improve regulatory capacity in low- and middle-income countries, especially those where clinical trials are planned or ongoing. The program supports the integration of ethical review, regulation, and registration of clinical trials in Africa. It promotes and strengthens the collaboration between ethical committees and regulatory authorities in the targeted African countries. Finally, it develops training material, including e-learning tools for national regulatory authorities and ethics committees.
